| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |